Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

“But the one thing new is a wondrous thing. The

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154612
(Total Views: 727)
Posted On: 12/13/2022 5:00:56 PM
Posted By: chazzledazzle
Re: ohm20 #131282
“But the one thing new is a wondrous thing. The results from the one macaque treated with AAV leronlimab is even greater than it appears. A functional cure for HIV would be amazing.”

This blew me away in the call. This and Dr Gluck’s confident chortle from time to time.

Re: HIV cure and Sacha’s prezie however, at least two other items made my neck hairs rise up.

First, probably much more obvious to the doctors on the board, but SIV, the Simian/Macaque version HIV shares the same envelope. So let me say it again another way. SIV has the HIV envelope and therefore would interact with cell membrane receptors such as CCR5 in the exact same way that HIV in humans will. So testing drugs in macaques is the holy grail for HIV research. The HIV envelope makes it so.

Therefore, even though we so far have patient zero to report on in that one little promiscuous as shit Macaque, we can be confident that his little SimianIVirus, with HIV envelope will act the same way concerning binding to CCR5 in humans.

Second, and here I go paraphrasing because the facts don’t matter if you know the story. Regarding the AAV assisted in vivo production of Leronlimab in Macaque patient zero, Jonah Sacha said another amazing thing. After the patient was dosed, the viral load went down right close to zero. But then it bounced back. Even though Leronlimab was being created in the little Master Bater, he got virus coming back. But then…………..

After day 8 or 9, or maybe it was week 8 or 9, the little fuckers virus went back down to zero. And remained at zero. That’s frickin’ incredible…bly positive news to me. I wonder what the blip was about. Which chemotaxis frankly. But incredible.


(12)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us